Clinical trial
Metformin in Castration-Resistant Prostate Cancer
NCT01215032
Study timeline
Study start (unknown)2010-09-01Date precision: month
Registry last updated2017-05-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
Dana-Farber Cancer Institutecollaborator
Brigham and Women's Hospitalcollaborator
Beth Israel Deaconess Medical Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01215032 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.